文献速递食管与纵隔外科

食管癌右胸与左胸入路十年生存比较

Ten-Year Survivals of Right Thoracic vs Left Thoracic Approach for Esophageal Cancer.
PubMed 文献 · Ann Thorac Surg · 2024-09-16

研究将300例食管癌患者随机分配至左胸或右胸入路食管切除术,按术后病理确诊的286例食管鳞癌进行符合方案分析。淋巴结转移患者中右胸组10年无病生存和总生存均优于左胸组。

核心结论

  • 与左胸入路相比,右胸入路食管切除术患者10年生存率更优,淋巴结转移患者生存获益显著。

研究设计与样本

  • 2010年5月至2012年7月间300例食管癌患者随机分配至左胸或右胸入路食管切除术,按符合方案原则分析286例术后病理确诊的食管鳞癌(右胸146例,左胸140例)。

临床怎么用

  • 右胸入路食管切除术可能为食管鳞癌患者带来更好的长期生存,尤其对淋巴结转移患者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Esophagectomy can be performed using various surgical techniques. The aim of this study was to understand the impact of surgery on long-term survival for esophageal cancer. METHODS: Between May 2010 and July 2012, 300 patients with esophageal cancer were randomly assigned to undergo esophagectomy with either a left or right thoracic approach. Disease-free survival (DFS) and overall survival (OS) were compared based on the per-protocol principle among 286 patients with esophageal squamous cell carcinoma determined by postoperative pathologic results (146 in the right and 140 in the left thoracic arms). RESULTS: The median DFS was 92 months in the right thoracic arm and 41 months in the left thoracic arm (hazard ratio, 0.73; 95% CI, 0.54-0.99; P = .045), with a cumulative 10-year DFS of 47.6% and 37.5%, respectively. The median OS was 136 months in the right thoracic arm and 99 months in the left thoracic arm (hazard ratio, 0.75; 95% CI, 0.54-1.04; P = .081), with cumulative 10-year OS of 52.4% and 43.7%, respectively. DFS and OS were comparable between the 2 arms for patients without lymph node metastasis. Conversely, for patients with lymph node metastasis, 10-year DFS was 32.7% and 21.4%, respectively (P = .018), and 10-year OS of the right and left thoracic arms was 37.9% and 25.9%, respectively (P = .012). CONCLUSIONS: Compared with the left thoracic approach, patients who underwent esophagectomy through the right thoracic approach had better 10-year survival rates, and the survival benefit was significant for those with lymph node metastasis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li B, Wang Z, Sun Y, et al. Ten-Year Survivals of Right Thoracic vs Left Thoracic Approach for Esophageal Cancer. Ann Thorac Surg. 2024. PMID: 39293749. doi:10.1016/j.athoracsur.2024.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。